Institute of Medicine, Chung Shan Medical University, Taiwan, ROC.
Thromb Res. 2012 Jan;129(1):43-9. doi: 10.1016/j.thromres.2011.08.011. Epub 2011 Sep 3.
Macrophage migration inhibitory factor (MIF) is an important cytokine in the modulation of inflammatory and immune responses, but its role in coagulation remains to be elucidated. In this study, we investigated the potential role of MIF in coagulation through its influence on two factors, thrombomodulin (TM) and intercellular adhesion molecule-1 (ICAM-1). Recombinant human MIF was added to human microvascular endothelial cell line (HMEC-1) to investigate its influence on the expression of TM and ICAM-1. The results showed that both TM and ICAM-1 were induced with MIF addition in a dose-dependent and time-dependent manner. The expression of ICAM-1 and TM was increased as MIF doses were increased, with the highest expression seen at 12 hr after 400 ng/ml of MIF treatment. Besides, anti-MIF antibody treatment reduced the TM expression in HMEC-1 cells. In conclusion, our data support a role of MIF as an important factor in the regulation of coagulation.
巨噬细胞移动抑制因子(MIF)是调节炎症和免疫反应的重要细胞因子,但它在凝血中的作用仍有待阐明。在这项研究中,我们通过研究 MIF 对血栓调节蛋白(TM)和细胞间黏附分子-1(ICAM-1)这两个因素的影响,来探究 MIF 在凝血中的潜在作用。我们向人微血管内皮细胞系(HMEC-1)中添加重组人 MIF,以研究其对 TM 和 ICAM-1 表达的影响。结果表明,MIF 以剂量和时间依赖的方式诱导 TM 和 ICAM-1 的表达。随着 MIF 剂量的增加,ICAM-1 和 TM 的表达增加,在 400ng/ml MIF 处理后 12 小时达到最高表达。此外,抗 MIF 抗体处理降低了 HMEC-1 细胞中的 TM 表达。总之,我们的数据支持 MIF 作为调节凝血的重要因素的作用。